Perspective Therapeutics, Inc. (CATX)

Last Closing Price: 3.03 (2026-06-05)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Perspective Therapeutics, Inc. (CATX) had Net Income of $-26.19M for the most recently reported fiscal quarter, ending 2026-03-31.

Figures for fiscal quarter ending 2026-03-31
Income Statement Financials
$0.08M
Net Income
$-26.19M
--
$0.08M
$28.36M
$-28.28M
$2.09M
$-26.19M
$-26.19M
$-26.19M
$-26.19M
$-26.19M
$-26.19M
$-28.28M
$-27.64M
103.60M
103.60M
$-0.25
$-0.25
Balance Sheet Financials
$275.35M
$92.48M
$135.42M
$410.77M
$31.49M
$1.55M
$31.84M
$63.33M
$347.44M
$307.44M
$347.44M
114.02M
Cash Flow Statement Financials
$-31.47M
$-109.55M
$164.36M
$30.63M
$53.97M
$23.34M
$2.55M
--
--
Fundamental Metrics & Ratios
8.75
--
--
0.00
0.00
100.00%
-37211.84%
-37211.84%
--
-34459.21%
-34459.21%
$-38.33M
--
--
--
0.00
--
1.31
68.68
-7.54%
-8.52%
-6.38%
-7.50%
$3.05
$-0.37
$-0.30